Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
15.09B | 14.89B | 15.62B | 16.67B | 13.80B | Gross Profit |
7.48B | 5.78B | 5.36B | 6.64B | 4.71B | EBIT |
1.11B | 622.00M | -69.00M | 1.14B | -862.00M | EBITDA |
1.61B | 1.17B | 489.43M | 994.00M | -403.00M | Net Income Common Stockholders |
844.00M | 502.00M | -202.00M | 256.00M | -665.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.59B | 1.87B | 1.22B | 877.00M | 2.40B | Total Assets |
11.88B | 11.04B | 11.39B | 12.76B | 13.77B | Total Debt |
5.47B | 5.44B | 6.02B | 6.25B | 7.66B | Net Debt |
3.14B | 3.57B | 4.80B | 5.37B | 5.68B | Total Liabilities |
8.62B | 8.45B | 9.15B | 10.04B | 11.15B | Stockholders Equity |
3.26B | 2.60B | 2.23B | 2.72B | 2.61B |
Cash Flow | Free Cash Flow | |||
1.04B | 1.11B | -78.00M | 115.00M | -155.00M | Operating Cash Flow |
1.49B | 1.53B | 607.00M | 809.00M | 237.00M | Investing Cash Flow |
-692.00M | -334.00M | -227.00M | -446.00M | -510.00M | Financing Cash Flow |
-321.00M | -567.00M | 6.00M | -1.47B | 895.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $4.58B | 11.60 | 17.56% | ― | 7.71% | 40.01% | |
73 Outperform | $7.20B | 8.70 | 28.81% | 3.14% | 1.32% | 65.83% | |
70 Outperform | $1.85B | 6.40 | 18.80% | 4.66% | 1.27% | 96.32% | |
69 Neutral | $1.77B | 8.91 | 46.71% | 4.04% | -3.44% | -11.74% | |
63 Neutral | $3.57B | 6.82 | 47.77% | ― | 15.60% | 71.45% | |
60 Neutral | $6.54B | 11.34 | 3.27% | 4.27% | 2.37% | -20.86% | |
55 Neutral | $1.13B | 96.91 | 0.62% | ― | -2.20% | ― |